Delivery Order SPE2DB20D1100-SPE2DB23FD5F8
Award Date 9/8/23
Potential Completion Date 9/29/23
Potential Value $43K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $22,018 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania from September 29th through October 23rd, 2023, this order is in support of the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were specified. The award utilizes an existing DLA medical product contract vehicle to procure this botulinum toxin, supporting the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $786 to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The contract has a period of performance from June 23 to July 17, 2023, with all work to be conducted in Conshohocken, Pennsylvania. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for a botulinum toxin appears to support routine medical needs within the DLA's supply chain...
- The Defense Logistics Agency awarded a $1,048 delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania under firm fixed price terms, the order runs from August 2nd to August 23rd, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency supports military readiness by procuring and providing logistics support and supplies to the Department of Defense and partners worldwide. This small order...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,718.16 to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding on August 1, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for the botulinum toxin appears to support routine medical needs. No subcontractors or set-aside designations were indicated.
- The Defense Logistics Agency awarded a $26,212 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania from August 9th to 30th, 2023, this order is likely placed against DLA's Pharmaceutical Prime Vendor contract to supply the agency's medical treatment facilities with necessary pharmaceutical products and services. No set aside designation or subcontractors are indicated. DLA manages the global supply chain for...
- The Defense Logistics Agency awarded a $1,572 delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania under firm fixed price terms, the order runs from August 8th to August 29th, 2023. As a leading supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will deliver the botulinum toxin under this short-term requirement to support the Agency's medical readiness and logistics programs. No...
- The Defense Logistics Agency awarded a $12,581.76 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 200 units of Xeomin, a botulinum toxin used for medical treatments. To be performed in Conshohocken, Pennsylvania under contract number 4562131839, the order runs from September 11th to October 2nd, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency supports America's armed forces by providing supplies in healthcare, construction...
- The Defense Logistics Agency awarded a $12,581.76 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 200 units of Xeomin, a botulinum toxin used for medical treatments. To be performed in Conshohocken, Pennsylvania under contract number 4562320831 from September 25, 2023 through October 17, 2023, this order is funded by DLA in support of Department of Defense requirements. No subcontractors or set aside designations were identified. DLA manages the...
- The Defense Logistics Agency awarded a $2,850 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 vials of Xeomin. To be performed in Conshohocken, Pennsylvania from July 13 to August 3, 2023, this order is issued against an existing DLA contract vehicle to supply the agency with pharmaceutical products in support of Department of Defense operations. As the prime, Amerisourcebergen Drug Corporation will deliver the botulinum toxin directly to DLA without involvement of...
- The Defense Logistics Agency awarded a $40,462 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. The contract has a period of performance from August 28, 2023 through September 19, 2023, with performance taking place in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corporation will deliver the botulinum toxin under this contract as the prime contractor, with oversight from the Defense Logistics Agency. No subcontractors or set aside...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB23FD5F8Delivery Order
The Defense Logistics Agency awarded a $42,854 delivery order to Amerisourcebergen Drug Corporation for 100 vials of Xeomin. To be performed in Conshohocken, Pennsylvania under firm fixed price terms, the order runs from September 8th through 29th, 2023. DLA facilitates medical commodity procurement for the Department of Defense, and this award continues their supply of botulinum toxin injections used for therapeutic purposes. No subcontractors or set aside designations were indicated. The short performance period and unit pricing suggest this supports ongoing DOD medical treatment requirements rather than a new program initiation or expansion.
Generated 12/17/23, 1:26 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $42.9k | 9/8/23 |